{"id":"W2245655230","doi":"10.1200/jco.2007.25.18_suppl.15506","title":"The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Subset analysis of patients (pts) with brain metastases (BM)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Sorafenib; Internal medicine; Renal cell carcinoma; Adverse effect; Population; Clinical endpoint; Clinical trial; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001379845,0.0006248566,0.001039303,0.0002501018,0.0002261108,0.0005190272,0.0004214692,0.0003601618,0.002794079],"category_scores_gemma":[0.0009309767,0.0002567794,0.0007167824,0.000387786,0.0003352533,0.0002897095,0.0003233511,0.0007631523,0.0003350469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003817067,"about_ca_system_score_gemma":0.0008797403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001011594,"about_ca_topic_score_gemma":0.002154526,"domain_scores_codex":[0.9995713,0.000249383,0.00002527895,0.00007217088,0.00003884477,0.00004309919],"domain_scores_gemma":[0.9994743,0.00009792297,0.0001097873,0.00006518084,0.00005385088,0.0001990019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8439345,0.01109236,0.09325335,0.0007976365,0.002783766,0.0006535836,0.0003270529,0.001990533,0.01423564,0.0002814655,0.004413568,0.02623667],"study_design_scores_gemma":[0.4917079,0.2075944,0.2740045,0.0001009576,0.004604478,0.002366085,0.0003225401,0.006708654,0.004937333,0.0005075057,0.007064105,0.00008142697],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982126,0.0001938317,0.00009006503,0.00004767319,0.00000766941,0.0004493723,0.0006254165,0.000008948527,0.0003645087],"genre_scores_gemma":[0.9964175,0.0001763712,0.0004048927,0.00009204989,0.00004264533,0.0005746001,0.001712762,0.000005692951,0.0005734308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002794079,"threshold_uncertainty_score":0.009347141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1106194677367489,"score_gpt":0.4725009566384316,"score_spread":0.3618814889016827,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}